December University of Galway consortia projects awarded over €19m in DTIF funding

Three consortia involving University of Galway researchers have received funding for innovative medtech, life sciences and AI-driven projects that will transform healthcare and drive improved patient outcomes. 

The funding, announced by Minister for Enterprise, Trade and Employment, Peter Burke T.D., is part of the latest tranche of awards from the Government’s Disruptive Technologies Innovation Fund (DTIF).

University of Galway is part of 38 consortia which have successfully applied for investment through partnerships with regional and national SMEs and institutions.

The three projects awarded funding in the latest round are:

The PIONEER project – a pathology and immuno-oncology with next-generation screening and electroporation for enhanced response in cancer therapy. The project is in partnership with Mirai Medical, Deciphex, Eurofins, University of Galway, Trinity College Dublin and University College Dublin. It has been awarded €7.2 million.

The HealAsystant project - an AI-assisted self-management support system for compression therapy. The project is in partnership with University of Galway spin-out FeelTect, Professional Granite Consulting and University of Galway. It has been awarded €6.3 million.

The RECAP project – a therapy and personalised post-treatment support for people with chronic musculoskeletal pain. It will involve a series of clinical trials that will combine two complimentary technologies. The project is in partnership with CrannMed, Salaso Health Solutions, University of Galway’s Institute for Clinical Trials and RCSI University of Medicine and Health Sciences. It has been awarded €6.6million.

Professor David Burn, President of University of Galway, said: “I am delighted to see University of Galway's continued success in awarded funding from the Government’s Disruptive Technologies Innovation Fund programme. Congratulations to all involved in this huge achievement and to the consortium of partners and those from the Galway region.

“These projects are a testament to the world-class research innovations in medtech, life sciences and AI-driven healthcare being developed at University of Galway to solve global challenges facing our society. The collaborative nature of our partnerships with institutions and enterprises demonstrates our ongoing commitment to advancing impactful research solutions.”

The Disruptive Technologies Innovation Fund finances collaboration between SMEs, multinationals and research institutions towards the development of the next wave of high-value innovation.

The total investment of over €19 million was made under the Government’s Call 7 of the Disruptive Technologies Innovation Fund.

Ends